癌变·畸变·突变

• 论著 • 上一篇    下一篇

精氨酸酶-1在原发性肝癌及肝转移癌鉴别中的作用

王斌生   

  1. 兰州大学第一医院普外科,甘肃  兰州  730000
  • 收稿日期:2013-06-14 修回日期:2013-10-13 出版日期:2014-03-30 发布日期:2014-03-30
  • 通讯作者: 王斌生(1981- ),男,甘肃省泾川县人,硕士,主治医师, 研究方向:普通外科。E-mail: bswang2006@126.com
  • 作者简介:王斌生(1981- ),男,甘肃省泾川县人,硕士,主治医师, 研究方向:普通外科。E-mail: bswang2006@126.com

Effects of arginase-1 in identifying primary hepatocellular carcinoma and hepatic metastasis

WANG Bin-sheng   

  1. General Surgery Department of the First Hospital of Lanzhou University,Lanzhou 730000,Gansu,China
  • Received:2013-06-14 Revised:2013-10-13 Online:2014-03-30 Published:2014-03-30
  • Contact: 王斌生(1981- ),男,甘肃省泾川县人,硕士,主治医师, 研究方向:普通外科。E-mail: bswang2006@126.com
  • About author:王斌生(1981- ),男,甘肃省泾川县人,硕士,主治医师, 研究方向:普通外科。E-mail: bswang2006@126.com

摘要:

目的: 探讨精氨酸酶-1(Arg-1)在原发性肝癌(PHC)和肝转移癌(HM)鉴别中的意义。方法:123例肝癌患者行超声引导下细针穿刺活检,标本制作成细胞块进行免疫组化染色,观察Arg-1表达情况。所有患者行手术切除后进行组织病理学诊断,结合细胞学、血清肿瘤标记物、临床及影像学随访结果进行最终判定。计算采用Arg-1鉴别PHC和HM的敏感度和特异性。结果:123例患者中PHC 78例,HM 45例。在PHC患者中,Arg-1呈高表达(83.3%)且以强染色为主(60.3%),高、中度分化肝细胞癌患者中阳性表达率(92.9%)高于低分化患者(76.9%),在胆管细胞型肝癌患者中不表达,在混合型肝癌患者中阳性表达率为75%;在HM患者中,Arg-1阳性表达率较低(8.9%),存在于结直肠癌、胰腺癌、乳腺癌肝转移患者中且均为弱染色,其他原发部位肝转移患者未见Arg-1阳性表达。Arg-1用于PHC和HM鉴别的敏感度为83.3%,特异性为91.1%。结论:细针穿刺活检标本行Arg-1免疫组化染色用于PHC和HM鉴别的敏感度和特异性均较高,值得进一步推广。

关键词: 精氨酸酶-1, 原发性肝癌, 肝转移癌, 细针穿刺活检

Abstract:

OBJECTIVE: To study the significance of arginase-1 (Arg-1) in identifying primary hepatic carcinoma (PHC) and hepatic metastasis (HM). METHODS:Fine-needle aspiration biopsies (FNABs) were performed in 123 patients,cell block were made and immunohistochemical staining were applied. The expression of arginase-1 was measured. All patients received surgical resection and histopathologic diagnosis were obtained. Cytology,serum tumor markers,clinical and radiographic follow-up results were used for a final decision. The sensitivity and specificity of Arg-1 in identifying PHC and HM were calculated. RESULTS:123 patients diagnosed to have PHC (78 cases) or HM (45 cases). High expression was present in PHC group (83.3%) and stained strongly (60.3%). Positive expression rate of highly and moderately differentiated patients (92.9%) were higher than lowly differentiated patients (76.9%),with no expression in cholangiocarcinoma patients. In the hybrid liver cancer patients the positive expression rate was 75%. In patients with HM,Arg-1 positive expression rate was low (8.9%) with weak staining,and were found in HM from colorectal cancer,pancreatic cancer. HM from other primary sites showed no Arg-1 positive expression. The sensitivity and specificity of Arg-1 in identifying PHC and HM were 83.3% and 91.1%,respectively. CONCLUSION: Arginase-1 may be a more sensitive marker of hepatocellular carcinoma (HCC) and hepatic metastasis. FNABs with Arg-1 immunohistochemical staining was sensitive and specific in identifying PHC and HM and warrant further promotion.

Key words: arginase-1, primary hepatic carcinoma, hepatic metastasis, fine-needle aspiration biopsy